PE-22-28: Reference Overview and Reconstitution Notes

PE-22-28 is a short, lab-made peptide (a small chain of amino acids) based on a natural compound called spadin. It blocks a brain protein called the TREK-1 potassium channel. It is studied in neuroscience and mood research. It is a research-only compound and is not approved by the FDA.

PE-22-28

What it is

PE-22-28 is a short, lab-made peptide (a small chain of amino acids, which are the building blocks of proteins). It is built from spadin, a natural fragment that the body produces from a larger protein called sortilin. In the research literature, PE-22-28 is described as a selective blocker of the TREK-1 channel. TREK-1 is a protein found in brain cells that acts like a tiny gate, controlling the flow of potassium (a charged particle) in and out of the cell. Blocking that gate changes how the cell sends signals.

Research context and categorization

Background and Development

PE-22-28 falls under the neuroscience, mood, and cognition research category. More specifically, it belongs to a group of peptides that work by changing the activity of ion channels. Ion channels are tiny gates in cell walls that open and close to let charged particles pass through. Think of them like valves in a water pipe. PE-22-28 was designed as a shorter, more stable version of spadin. Spadin was first described around 2010 as a natural TREK-1 blocker that showed antidepressant-like effects in animal studies.

Preclinical Targets and Research

In research settings, PE-22-28 is studied mainly because of its connection to the TREK-1 channel. Lab animals that are missing this channel show a depression-resistant profile, meaning they are less likely to display depression-like behavior in standard tests. Because of this link, PE-22-28 is investigated for possible effects on mood-related behavior, neurogenesis (the growth of new brain cells), and neuroprotection (shielding existing brain cells from damage). All of this work is done in cells and animals, not in people.

Research reports also note that PE-22-28 may act more quickly and last longer than the original spadin peptide it was based on.

Key point: PE-22-28 is strictly for investigational use. There are no completed, published human trials. None of the effects described here are confirmed or approved outcomes in people.

Status

• Regulatory status: Research-only, not FDA-approved. PE-22-28 is not approved for any medical use. It is handled as an investigational research compound. All published work is limited to cell and rodent studies.
• Sport status: PE-22-28 is not listed by name on the WADA Prohibited List (the global list of substances banned in competitive sport). TREK-1 channel blockers are also not a named class on that list. Because the list uses broad category language and is updated regularly, anyone with a competitive-sport concern should check the current official WADA Prohibited List directly.

Reconstitution notes (general)

Reconstitution means dissolving a dry powder in liquid to make a working solution at the lab bench. The math is simple: concentration equals the milligrams of peptide in the vial divided by the millilitres of bacteriostatic water added. Think of it like mixing a juice concentrate. More water makes a weaker mix. Less water makes a stronger mix. To figure out the exact concentration for a specific vial, use the peptide calculator.

Dilution and handling notes (compound-specific)

PE-22-28 is supplied as a lyophilized (freeze-dried) powder, most often in vials holding 5 mg to 10 mg. It is dissolved in bacteriostatic water (a sterile water with a small amount of preservative that slows bacterial growth). Common lab references suggest using roughly 1 mL to 3 mL of bacteriostatic water per vial. For a 10 mg vial, that gives a concentration of about 3 to 10 mg per mL.

How much water you use is a trade-off. Less water gives a stronger, smaller-volume solution. More water makes it easier to measure small amounts accurately.

Mixing Instructions

PE-22-28 has parts of its structure that do not mix easily with water (called hydrophobic residues, meaning they tend to push water away). Because of this, a freshly mixed vial may look slightly cloudy at first and may take longer to fully dissolve than other peptides. To mix it properly:

1. Add the water slowly along the inner wall of the vial, not directly onto the powder.
2. Let the vial sit, then swirl or roll it gently until the liquid turns clear. Do not shake it. Shaking causes foam and can stress the peptide.
3. Let the powder and the water reach room temperature before mixing. This helps the powder dissolve and reduces cloudiness.
4. If the solution is still cloudy or has visible bits floating in it after gentle mixing and resting, treat that as incomplete dissolution. It is not ready to use yet.

Handling and storage

Keep the reconstituted (dissolved) solution refrigerated at 2 to 8 C and away from direct light. Wipe the rubber stopper with an alcohol swab before each use. Write the mix date on the vial label so you always know how old the solution is.

Plan to use or discard the reconstituted solution within a general four-week refrigerated window. If the powder has not been mixed yet, keep it frozen for longer-term storage as your supplier directs.

When to Discard

Discard the solution right away if you notice any of the following:

• It turns cloudy after it had already gone clear
• It changes color
• It has floating bits or visible particles in it

Related reading

• PEG-MGF
• Pinealon
• PNC-27
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is PE-22-28 and what does it do in research?

PE-22-28 is a short synthetic peptide derived from spadin that selectively blocks the TREK-1 potassium channel in brain cells. It is studied in cell and rodent models for effects on mood-related behavior, neurogenesis, and neuroprotection.

Is PE-22-28 FDA-approved or listed on the WADA prohibited list?

PE-22-28 is not FDA-approved for any use and is handled as an investigational research compound. It is not listed by name on the WADA Prohibited List; those with sport-compliance concerns should consult the current official WADA list directly.

How do you reconstitute PE-22-28 powder for laboratory use?

Add a measured volume of bacteriostatic water to the dry peptide vial. Concentration (mg/mL) equals milligrams in the vial divided by milliliters added. Use a peptide calculator to determine the exact volume for your target concentration.

What the research community gets wrong about PE-22-28

• Treating PE-22-28 and spadin as the same thing. In the literature PE-22-28 is a shortened analog built from spadin, not a nickname for it. Studies report it blocks the TREK-1 channel at far lower concentrations than spadin (a reported IC50 near 0.12 nM versus about 40 to 60 nM for spadin). They are different molecules with different reported potency, so a label that says one is not describing the other.
• Reading the word "antidepressant" as a proven human result. In the papers that term describes behavior in rodent tests and effects in cells, not confirmed outcomes in people. There are no completed, published human trials. At the bench this is an investigational research compound, nothing more.
• Expecting it to dissolve like an easy peptide. Its sequence has parts that push water away (hydrophobic residues), so a freshly mixed vial can look cloudy and take longer to clear than other peptides. Early cloudiness after gentle swirling is common and is not automatic proof the powder is bad. Cloudiness that returns after the solution had gone clear is the signal to discard.
• Assuming the exact sequence on the label does not matter. The studies found that small changes to the ends of the peptide (terminal modifications) changed its reported TREK-1 activity. So the precise sequence, and any modifications noted on a vial, describe a different material to handle, not a rounding detail.
• Giving dry powder and dissolved solution the same shelf life. The freeze-dried (lyophilized) powder and the reconstituted solution are handled differently. The dissolved solution is the less stable form and follows a much shorter refrigerated window than the sealed dry vial.

From our bench: PE-22-28 is often described as slow to dissolve because of its water-avoiding parts, and we want real reconstitution notes rather than guesses. If you have mixed a vial, tell us the vial size (in mg), how much bacteriostatic water you added, and roughly how long the solution took to go fully clear after gentle swirling at room temperature. Did any cloudiness or floating bits remain after it settled? Share your own measured numbers so other researchers can compare against their bench results.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. Djillani A, et al. Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. Front Pharmacol. 2017 (PMID 28955242)
5. Djillani A, et al. Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. Pharmacol Ther. 2019 (PMID 30291907)
6. Mazella J, et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol. 2010 (PMID 20405001)